Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

This study has been completed.

Study NCT00071422 Information provided by Procter and Gamble

First Received: October 22, 2003 Last Updated: July 22, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2004
Primary Completion Date:	June 2004 (Final data collection date for primary outcome measure)